Total Payments
$15,429
2024 Payments
$3,656
Companies
57
Transactions
913
Medicare Patients
2,717
Medicare Billing
$306,215
Payment Breakdown by Category
Food & Beverage$15,143 (98.1%)
Travel$210.15 (1.4%)
Other$75.41 (0.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $15,143 | 908 | 98.1% |
| Travel and Lodging | $210.15 | 1 | 1.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $75.41 | 4 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,606 | 101 | $0 (2024) |
| UCB, Inc. | $1,369 | 78 | $0 (2024) |
| LivaNova USA, Inc. | $1,051 | 24 | $0 (2024) |
| SK Life Science, Inc. | $778.55 | 37 | $0 (2024) |
| Lilly USA, LLC | $657.93 | 34 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $655.12 | 56 | $0 (2024) |
| Amgen Inc. | $649.31 | 55 | $0 (2022) |
| Celgene Corporation | $649.15 | 68 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $615.14 | 30 | $0 (2024) |
| HARMONY BIOSCIENCES LLC | $530.29 | 47 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,656 | 206 | ABBVIE INC. ($648.81) |
| 2023 | $3,069 | 191 | AbbVie Inc. ($459.69) |
| 2022 | $3,588 | 185 | LivaNova USA, Inc. ($672.37) |
| 2021 | $1,721 | 107 | SK Life Science, Inc. ($219.44) |
| 2020 | $719.35 | 44 | UCB, Inc. ($127.85) |
| 2019 | $1,233 | 87 | UCB, Inc. ($163.03) |
| 2018 | $765.99 | 56 | Impax Laboratories, Inc. ($163.15) |
| 2017 | $676.62 | 37 | UCB, Inc. ($187.25) |
All Payment Transactions
913 individual payment records from CMS Open Payments — Page 1 of 37
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | LivaNova USA, Inc. | VNS THERAPY SENTIVA MODEL 1000 GENERATOR (Device) | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: Neurology | ||||||
| 12/17/2024 | Biogen, Inc. | QALSODY (Drug), SPINRAZA | Food and Beverage | In-kind items and services | $19.04 | General |
| Category: Neurology | ||||||
| 12/17/2024 | UCB, Inc. | Zilbrysq (Drug) | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: Neurology | ||||||
| 12/17/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $5.81 | General |
| Category: NEUROSCIENCE | ||||||
| 12/13/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $19.08 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/12/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $18.19 | General |
| Category: EPILEPSY | ||||||
| 12/11/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $16.53 | General |
| 12/09/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $20.66 | General |
| Category: Neurology | ||||||
| 12/09/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $8.41 | General |
| Category: NEUROSCIENCE | ||||||
| 12/09/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $2.57 | General |
| Category: Neurology | ||||||
| 12/05/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $13.97 | General |
| Category: Neuroscience | ||||||
| 12/03/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $24.75 | General |
| Category: NEUROSCIENCE | ||||||
| 12/02/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $23.34 | General |
| Category: PAIN | ||||||
| 11/21/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: Neurology | ||||||
| 11/20/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $4.58 | General |
| Category: Neuroscience | ||||||
| 11/12/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $20.56 | General |
| Category: NEUROSCIENCE | ||||||
| 11/11/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $19.90 | General |
| Category: Neuropsychiatry | ||||||
| 11/08/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $19.05 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/07/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $23.04 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 11/06/2024 | Abbott Laboratories | INFINITY (Device) | Food and Beverage | In-kind items and services | $23.63 | General |
| Category: Neuromodulation | ||||||
| 11/06/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $19.63 | General |
| Category: EPILEPSY | ||||||
| 11/05/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $12.38 | General |
| Category: Neuroscience | ||||||
| 10/31/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $2.58 | General |
| Category: NEUROSCIENCE | ||||||
| 10/30/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: Neurology | ||||||
| 10/30/2024 | LivaNova USA, Inc. | VNS THERAPY SENTIVA MODEL 1000 GENERATOR (Device) | Food and Beverage | In-kind items and services | $11.01 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 589 | 786 | $247,701 | $70,781 |
| 2022 | 3 | 613 | 811 | $239,326 | $74,802 |
| 2021 | 4 | 730 | 882 | $261,903 | $84,407 |
| 2020 | 8 | 785 | 972 | $273,619 | $76,225 |
Total Patients
2,717
Total Services
3,451
Medicare Billing
$306,215
Procedure Codes
18
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 448 | 645 | $184,880 | $53,940 | 29.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 141 | 141 | $62,821 | $16,842 | 26.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 444 | 642 | $171,679 | $54,877 | 32.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 157 | 157 | $65,458 | $19,154 | 29.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 12 | 12 | $2,190 | $771.94 | 35.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 437 | 586 | $155,981 | $53,987 | 34.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 154 | 154 | $63,158 | $19,373 | 30.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 125 | 128 | $23,223 | $6,264 | 27.0% |
| 95819 | Measurement and recording of brain wave (eeg) activity, awake and asleep | Office | 2021 | 14 | 14 | $19,542 | $4,783 | 24.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 499 | 672 | $122,341 | $35,039 | 28.6% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 118 | 118 | $60,843 | $17,881 | 29.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 78 | 80 | $48,462 | $12,832 | 26.5% |
| 95819 | Measurement and recording of brain wave (eeg) activity, awake and asleep | Office | 2020 | 11 | 11 | $15,354 | $3,414 | 22.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 24 | 35 | $7,463 | $2,014 | 27.0% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Facility | 2020 | 14 | 14 | $7,233 | $1,882 | 26.0% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 13 | 13 | $5,315 | $1,405 | 26.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 12 | 12 | $3,090 | $1,017 | 32.9% |
| 95816 | Measurement and recording of brain wave (eeg) activity, awake and drowsy | Facility | 2020 | 16 | 17 | $3,517 | $740.55 | 21.1% |
About Dr. Douglas Sullivant, MD
Dr. Douglas Sullivant, MD is a Neurology healthcare provider based in Quincy, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1467425603.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Douglas Sullivant, MD has received a total of $15,429 in payments from pharmaceutical and medical device companies, with $3,656 received in 2024. These payments were reported across 913 transactions from 57 companies. The most common payment nature is "Food and Beverage" ($15,143).
As a Medicare-enrolled provider, Sullivant has provided services to 2,717 Medicare beneficiaries, totaling 3,451 services with total Medicare billing of $306,215. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Quincy, IL
- Active Since 02/08/2006
- Last Updated 02/12/2010
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1467425603
Products in Payments
- Briviact (Drug) $977.76
- UBRELVY (Drug) $752.82
- VNS Therapy (Device) $691.68
- NURTEC ODT (Drug) $626.75
- ZEPOSIA (Drug) $618.67
- Aimovig (Biological) $536.62
- INGREZZA (Drug) $489.54
- BOTOX (Biological) $483.76
- EMGALITY (Drug) $455.51
- NUPLAZID (Drug) $372.07
- WAKIX (Drug) $369.29
- AUBAGIO (Drug) $346.88
- OCREVUS (Biological) $346.22
- VALTOCO (Drug) $345.53
- VYVGART (Drug) $329.61
- VNS THERAPY SENTIVA MODEL 1000 GENERATOR (Device) $307.90
- VYEPTI (Biological) $267.87
- TYSABRI (Biological) $266.95
- QULIPTA (Drug) $248.66
- RYTARY (Drug) $245.45
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Quincy
Dr. Anil Nair, Md, MD
Neurology — Payments: $326,656
Neurology $326,656
Dr. Austin Hake, M.d, M.D
Neurology — Payments: $31,910
Neurology $31,910
Dr. Daniel Kimple, Md, MD
Neurology — Payments: $13,762
Neurology $13,762
Dr. Ahmed Jouan
Neurology — Payments: $9,921
Neurology $9,921
James Won, Md, MD
Neurology — Payments: $691.46
Neurology $691.46
Linda Johnson, M.d, M.D
Neurology — Payments: $16.83
Neurology $16.83